Literature DB >> 3361653

Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. I. Testing of a digitization system.

J L Mohler1, A W Partin, W D Lohr, D S Coffey.   

Abstract

Standard pathological grading systems for prostatic carcinoma based upon glandular architectural pattern or nuclear anaplasia have failed to predict the prognosis of individual patients. Quantitative morphometric analysis of nuclear shape has predicted the outcome of patients with prostatic carcinoma when evaluated by some but not all reported studies. Calculation of nuclear roundness factor by different investigators was complicated by equipment differences and lack of standardized methods for acquiring and reporting data. We have improved our system for nuclear contour digitization and determined its theoretical limitations by digitizing standardized objects. Measurement errors were independent of orientation or location of an object within a microscopic or digitizer tablet field, speed of digitization and introduction of a microscope extension tube and light emitting diode cursor. Perimeters and areas of circles and squares of actual or digitizer-projected diameter or sidelength greater than five mm. were measured with a reproducibility and accuracy of greater than or equal to 90%. When a microscopic circle of diameter similar to prostatic carcinoma nuclei was digitized at a magnification of 2580 X, perimeter and area measurements differed within or between observers by less than 5% and were more than 95% accurate. In order to calculate accurately and evaluate NRF for use in assessing the prognosis of patients with prostatic carcinoma investigators must precisely describe their digitization system, standardization method and observer reproducibility and accuracy when measuring circles that approximate the projected size of prostatic carcinoma nuclei.

Entities:  

Mesh:

Year:  1988        PMID: 3361653     DOI: 10.1016/s0022-5347(17)42791-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  Nuclear morphometry, nucleomics and prostate cancer progression.

Authors:  Robert W Veltri; Christhunesa S Christudass; Sumit Isharwal
Journal:  Asian J Androl       Date:  2012-04-16       Impact factor: 3.285

Review 2.  Structure and function analysis in circulating tumor cells: using nanotechnology to study nuclear size in prostate cancer.

Authors:  Nu Yao; Yu-Jen Jan; Shirley Cheng; Jie-Fu Chen; Leland Wk Chung; Hsian-Rong Tseng; Edwin M Posadas
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

3.  Accumulation of iron by primary rat hepatocytes in long-term culture: changes in nuclear shape mediated by non-transferrin-bound forms of iron.

Authors:  E E Cable; J R Connor; H C Isom
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

4.  Epithelial-mesenchymal transition in prostate cancer is associated with quantifiable changes in nuclear structure.

Authors:  James E Verdone; Princy Parsana; Robert W Veltri; Kenneth J Pienta
Journal:  Prostate       Date:  2014-10-18       Impact factor: 4.104

5.  Association between Nuclear Morphometry Parameters and Gleason Grade in Patients with Prostatic Cancer.

Authors:  Kamil Malshy; Gilad E Amiel; Dov Hershkovitz; Edmond Sabo; Azik Hoffman
Journal:  Diagnostics (Basel)       Date:  2022-05-31

6.  Improved prediction of prostate cancer recurrence through systems pathology.

Authors:  Carlos Cordon-Cardo; Angeliki Kotsianti; David A Verbel; Mikhail Teverovskiy; Paola Capodieci; Stefan Hamann; Yusuf Jeffers; Mark Clayton; Faysal Elkhettabi; Faisal M Khan; Marina Sapir; Valentina Bayer-Zubek; Yevgen Vengrenyuk; Stephen Fogarsi; Olivier Saidi; Victor E Reuter; Howard I Scher; Michael W Kattan; Fernando J Bianco; Thomas M Wheeler; Gustavo E Ayala; Peter T Scardino; Michael J Donovan
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

7.  Carnegie Mellon University bioimaging day 2014: Challenges and opportunities in digital pathology.

Authors:  Gustavo K Rohde; John A Ozolek; Anil V Parwani; Liron Pantanowitz
Journal:  J Pathol Inform       Date:  2014-08-28

8.  Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancer.

Authors:  Robert W Veltri; Christhunesa S Christudass
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.